Leadership Roles

•  Founder & Chairman. Sail Group
• Director, China Medicinal Biotechnology Association
• Director, China Center for Neural Stem Cell Transplantation Therapy
• President, Shandong Red Cross Interventional Hospital
• Academic & Professional Credentials
• Member. American Association for Cancer Research (AACR).
•  Member of American Academy of Anti-Aging Medicine (A4M)

Key Contributions

• Stem Cell Therapy Innovations:
• Developed breakthrough treatments for type 2 diabetes, demonstrating reductions in HbA1c, blood glucose, and hypertension through stem cell transplantation.
• Advanced neural stem cell therapies for Parkinson’s disease and spinal cord injury.
  improving patient mobility and quality of life.
• Established clinical safety protocolsfor pluripotent stem cell applications, validated through 5-year follow-up studies.
• Clinical Leadership : Bridged biotechnology research with clinical practice, transforming interventional medicine in China.

Selected Publications

1. Computer-Assisted Stereotactic Transplantation of Human Neural Stem Cells in Parkinson’s Disease *Acta Scientific Medical Sciences* (2018).
2. ERRγ-Overexpressing Stem Cells Improve Type 2 Diabetes Symptoms *Adv Tissue Eng Regen Med Open Access* (2018).
3. Stem Cell Therapy Reduces Hypertension in T2D Patients, *Stem Cells Regen Med* (2019).
4. Long-Term Safety of Human Pluripotent Stem Cell Transplantation, *Stem Cells Regen Med* (2021).
5. Physical Recovery in Spinal Cord Injury Patients Post Stem Cell Therapy *Adv Tissue Eng Regen Med Open Access* (2017)

Impact

A visionary leader in regenerative medicine, driving translational research from lab to clinic to address chronic diseases and neurological disorders